A new research has proposed that the gene behind the development of breast cancer in females and prostate cancer in males has been identified. It is being expected that the discovery of the gene would help treatments that could detect the tumors at an early stage in the gland of male reproductive system.
A team of researchers from The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust in the UK identified this gene BRCA1, capable of increasing the chances of development of prostate cancer by the age of 65.
During the course of the study, as many as 913 men underwent genetic screening, out of which four men were discovered to have alterations in the gene BRCA1. Further, after analysis, it was discovered that three men out of the four were suffering from prostate cancer.
The study author, Prof Ros Eeles, from The Institute of Cancer Research, stated that prior to the findings of the study, there were confusions related to the fact that whether alterations in the gene could increase the risk of disease, but with the findings obtained from the study, there are no doubts left.
He said, “This large study has shown that men with prostate cancer have a one in 200 chance of having an alteration of this gene and men with this alteration have a 3.8 fold increased risk of developing the disease”.
It has been estimated that the findings of the study suggest that the gene triggers the chance of development by one in 11 in case of men and six in 10 chances of development of breast cancer in women with this gene.
However, the positive reports regarding the issue are that men can be detected for the alteration of this gene and further, treatments are available that specifically target the gene.
- Postage Prices will Decrease from Sunday; USPS not too Happy About It
- Marriott and Starwood Hotels & Resorts Worldwide Inc Shareholders Approve to $14.41 Sales Deal
- UK plan to impose additional tax on sugary drinks
- Obesity during pregnancy may increase risk of very ‘large babies’
- Dropping Sales at Gap’s Key Brands hurt the Company’s Shares